Karen J. Wilson

Insider · Director · ELTX

Karen J. Wilson files insider transactions with the SEC as a director of Elicio Therapeutics (ELTX). We hold 4 disclosed purchases and sales filed since 11 May 2009, 2 of them in the last 90 days.

Files forELTX
Disclosed buys and sells4 in all, 2 in the last 90 days
Last disclosure15 June 2026

Positions held

7 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 28 December 2023 — 31 August 2026Director · Elicio Therapeutics (ELTX)4 Form 4 lines · source: SEC Form 4
Filed 14 January 2025 — 17 June 2026Director · Serina Therapeutics (SER)7 Form 4 lines · source: SEC Form 4
Filed 13 February 2025 — 13 November 2025Director · LAVA Therapeutics NV (LVTX)3 Form 4 lines · source: SEC Form 4
Filed 9 February 2021 — 9 June 2022Director · Angion Biomedica (ANGN)4 Form 4 lines · source: SEC Form 4
Filed 25 August 2020 — 16 June 2021Director · Vaxart (VXRT)2 Form 4 lines · source: SEC Form 4
Filed 10 March 2011 — 5 March 2019SVP, Finance & PAO · Jazz Pharmaceuticals (JAZZ)104 Form 4 lines · source: SEC Form 4
Filed 7 May 2009 — 7 May 2009VP of Finance & PAO · Pdl Biopharma (PDLI)1 Form 4 line · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

was granted 21,750 shares of Elicio Therapeutics (a derivative holding)SEC Form 42 September 2026Stock Option (Right to Buy) · traded 31 August 2026 · filed 2 September 2026
was granted 15,250 shares of Serina Therapeutics (a derivative holding)SEC Form 422 June 2026Stock Option (right to buy) · traded 17 June 2026 · filed 22 June 2026
▲ bought on the open market 5,100 shares of Serina TherapeuticsSEC Form 415 June 2026Common Stock · traded 11 June 2026 · filed 15 June 2026
▲ bought on the open market 5,000 shares of Serina TherapeuticsSEC Form 415 June 2026Common Stock · traded 12 June 2026 · filed 15 June 2026
▲ bought on the open market 10,000 shares of Serina TherapeuticsSEC Form 426 May 2026Common Stock · traded 21 May 2026 · filed 26 May 2026
▲ bought on the open market 10,000 shares of Serina TherapeuticsSEC Form 426 May 2026Common Stock · traded 22 May 2026 · filed 26 May 2026
returned to the issuer 33,390 shares of LAVA Therapeutics NV (a derivative holding)SEC Form 417 November 2025Share Options (Right to Buy) · traded 13 November 2025 · filed 17 November 2025
returned to the issuer 10,000 shares of LAVA Therapeutics NVSEC Form 417 November 2025Common Shares · traded 13 November 2025 · filed 17 November 2025
was granted 10,000 shares of Serina Therapeutics (a derivative holding)SEC Form 410 November 2025Stock Option (right to buy) · traded 7 November 2025 · filed 10 November 2025
was granted 7,900 shares of Elicio Therapeutics (a derivative holding)SEC Form 420 May 2025Stock Option (Right to Buy) · traded 19 May 2025 · filed 20 May 2025
was granted 33,390 shares of LAVA Therapeutics NV (a derivative holding)SEC Form 418 February 2025Common Shares (Right to Buy) · traded 13 February 2025 · filed 18 February 2025
was granted 40,000 shares of Serina Therapeutics (a derivative holding)SEC Form 415 January 2025Stock Option (right to buy) · traded 14 January 2025 · filed 15 January 2025
was granted 4,100 shares of Elicio Therapeutics (a derivative holding)SEC Form 425 November 2024Stock Option (Right to Buy) · traded 21 November 2024 · filed 25 November 2024
was granted 4,100 shares of Elicio Therapeutics (a derivative holding)SEC Form 429 December 2023Stock Option (right to buy) · traded 28 December 2023 · filed 29 December 2023
was granted 15,000 shares of Angion Biomedica (a derivative holding)SEC Form 413 June 2022Common Stock · traded 9 June 2022 · filed 13 June 2022
was granted 15,097 shares of Vaxart (a derivative holding)SEC Form 417 June 2021Stock Option (right to buy) · traded 16 June 2021 · filed 17 June 2021
was granted 15,000 shares of Angion Biomedica (a derivative holding)SEC Form 410 March 2021Stock Option (Right to Buy) · traded 8 March 2021 · filed 10 March 2021
converted an unstated number of shares of Angion Biomedica (a derivative holding)SEC Form 411 February 2021Convertible Promissory Note · traded 9 February 2021 · filed 11 February 2021
converted 18,718 shares of Angion BiomedicaSEC Form 411 February 2021Common Stock · traded 9 February 2021 · filed 11 February 2021
was granted 65,700 shares of Vaxart (a derivative holding)SEC Form 427 August 2020Stock Option (right to buy) · traded 25 August 2020 · filed 27 August 2020
had shares withheld for tax on 276 shares of Jazz PharmaceuticalsSEC Form 47 March 2019Ordinary Shares · traded 5 March 2019 · filed 7 March 2019
had shares withheld for tax on 302 shares of Jazz PharmaceuticalsSEC Form 47 March 2019Ordinary Shares · traded 5 March 2019 · filed 7 March 2019
was granted 576 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 44 March 2019Incentive Stock Option (right to buy) · traded 28 February 2019 · filed 4 March 2019
was granted 8,174 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 44 March 2019Non-Qualified Stock Option (right to buy) · traded 28 February 2019 · filed 4 March 2019
was granted 3,500 shares of Jazz PharmaceuticalsSEC Form 44 March 2019Ordinary Shares · traded 28 February 2019 · filed 4 March 2019
had shares withheld for tax on 310 shares of Jazz PharmaceuticalsSEC Form 427 February 2019Ordinary Shares · traded 25 February 2019 · filed 27 February 2019
had shares withheld for tax on 230 shares of Jazz PharmaceuticalsSEC Form 427 February 2019Ordinary Shares · traded 26 February 2019 · filed 27 February 2019
▼ sold on the open market 3,706 shares of Jazz PharmaceuticalsSEC Form 415 May 2018Ordinary Shares · traded 11 May 2018 · filed 15 May 2018
▼ sold on the open market 54 shares of Jazz PharmaceuticalsSEC Form 415 May 2018Ordinary Shares · traded 11 May 2018 · filed 15 May 2018
▼ sold on the open market 3,899 shares of Jazz PharmaceuticalsSEC Form 412 April 2018Ordinary Shares · traded 10 April 2018 · filed 12 April 2018
had shares withheld for tax on 302 shares of Jazz PharmaceuticalsSEC Form 47 March 2018Ordinary Shares · traded 5 March 2018 · filed 7 March 2018
was granted 3,200 shares of Jazz PharmaceuticalsSEC Form 45 March 2018Ordinary Shares · traded 1 March 2018 · filed 5 March 2018
was granted 681 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 45 March 2018Incentive Stock Option (right to buy) · traded 1 March 2018 · filed 5 March 2018
was granted 7,319 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 45 March 2018Non-Qualified Stock Option (right to buy) · traded 1 March 2018 · filed 5 March 2018
had shares withheld for tax on 537 shares of Jazz PharmaceuticalsSEC Form 428 February 2018Ordinary Shares · traded 26 February 2018 · filed 28 February 2018
had shares withheld for tax on 324 shares of Jazz PharmaceuticalsSEC Form 428 February 2018Ordinary Shares · traded 27 February 2018 · filed 28 February 2018
▼ sold on the open market 1,275 shares of Jazz PharmaceuticalsSEC Form 427 April 2017Ordinary Shares · traded 27 April 2017 · filed 27 April 2017
exercised options over 4,750 shares of Jazz PharmaceuticalsSEC Form 411 April 2017Ordinary Shares · traded 10 April 2017 · filed 11 April 2017
▼ sold on the open market 4,750 shares of Jazz PharmaceuticalsSEC Form 411 April 2017Ordinary Shares · traded 10 April 2017 · filed 11 April 2017
exercised options over 6,708 shares of Jazz PharmaceuticalsSEC Form 411 April 2017Ordinary Shares · traded 10 April 2017 · filed 11 April 2017
▼ sold on the open market 6,708 shares of Jazz PharmaceuticalsSEC Form 411 April 2017Ordinary Shares · traded 10 April 2017 · filed 11 April 2017
exercised options over 6,708 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 411 April 2017Non-Qualified Stock Option (right to buy) · traded 10 April 2017 · filed 11 April 2017
exercised options over 4,750 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 411 April 2017Non-Qualified Stock Option (right to buy) · traded 10 April 2017 · filed 11 April 2017
had shares withheld for tax on 563 shares of Jazz PharmaceuticalsSEC Form 48 March 2017Ordinary Shares · traded 6 March 2017 · filed 8 March 2017
exercised options over 2,896 shares of Jazz PharmaceuticalsSEC Form 48 March 2017Ordinary Shares · traded 8 March 2017 · filed 8 March 2017
exercised options over 750 shares of Jazz PharmaceuticalsSEC Form 48 March 2017Ordinary Shares · traded 8 March 2017 · filed 8 March 2017
exercised options over 2,896 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 48 March 2017Incentive Stock Option (right to buy) · traded 8 March 2017 · filed 8 March 2017
exercised options over 750 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 48 March 2017Incentive Stock Option (right to buy) · traded 8 March 2017 · filed 8 March 2017
was granted 3,500 shares of Jazz PharmaceuticalsSEC Form 46 March 2017Ordinary Shares · traded 2 March 2017 · filed 6 March 2017
was granted 969 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 46 March 2017Incentive Stock Option (right to buy) · traded 2 March 2017 · filed 6 March 2017
was granted 7,781 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 46 March 2017Non-Qualified Stock Option (right to buy) · traded 2 March 2017 · filed 6 March 2017
had shares withheld for tax on 935 shares of Jazz PharmaceuticalsSEC Form 41 March 2017Ordinary Shares · traded 27 February 2017 · filed 1 March 2017
had shares withheld for tax on 1,467 shares of Jazz PharmaceuticalsSEC Form 411 August 2016Ordinary Shares · traded 9 August 2016 · filed 11 August 2016
▼ sold on the open market 604 shares of Jazz PharmaceuticalsSEC Form 427 April 2016Ordinary Shares · traded 25 April 2016 · filed 27 April 2016
▼ sold on the open market 5,007 shares of Jazz PharmaceuticalsSEC Form 415 April 2016Ordinary Shares · traded 13 April 2016 · filed 15 April 2016
▼ sold on the open market 2,161 shares of Jazz PharmaceuticalsSEC Form 48 April 2016Ordinary Shares · traded 7 April 2016 · filed 8 April 2016
had shares withheld for tax on 563 shares of Jazz PharmaceuticalsSEC Form 49 March 2016Ordinary Shares · traded 7 March 2016 · filed 9 March 2016
had shares withheld for tax on 348 shares of Jazz PharmaceuticalsSEC Form 42 March 2016Ordinary Shares · traded 29 February 2016 · filed 2 March 2016
was granted 3,300 shares of Jazz PharmaceuticalsSEC Form 429 February 2016Ordinary Shares · traded 25 February 2016 · filed 29 February 2016
had shares withheld for tax on 285 shares of Jazz PharmaceuticalsSEC Form 429 February 2016Ordinary Shares · traded 26 February 2016 · filed 29 February 2016
was granted 739 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 429 February 2016Incentive Stock Option (right to buy) · traded 25 February 2016 · filed 29 February 2016
was granted 7,511 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 429 February 2016Non-Qualified Stock Option (right to buy) · traded 25 February 2016 · filed 29 February 2016
had shares withheld for tax on 1,956 shares of Jazz PharmaceuticalsSEC Form 411 August 2015Ordinary Shares · traded 10 August 2015 · filed 11 August 2015
exercised options over 1,500 shares of Jazz PharmaceuticalsSEC Form 43 June 2015Ordinary Shares · traded 1 June 2015 · filed 3 June 2015
▼ sold on the open market 1,500 shares of Jazz PharmaceuticalsSEC Form 43 June 2015Ordinary Shares · traded 1 June 2015 · filed 3 June 2015
exercised options over 3,994 shares of Jazz PharmaceuticalsSEC Form 43 June 2015Ordinary Shares · traded 1 June 2015 · filed 3 June 2015
▼ sold on the open market 3,994 shares of Jazz PharmaceuticalsSEC Form 43 June 2015Ordinary Shares · traded 1 June 2015 · filed 3 June 2015
▼ sold on the open market 257 shares of Jazz PharmaceuticalsSEC Form 43 June 2015Ordinary Shares · traded 2 June 2015 · filed 3 June 2015
exercised options over 3,994 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 43 June 2015Non-Qualified Stock Option (right to buy) · traded 1 June 2015 · filed 3 June 2015
exercised options over 1,500 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 43 June 2015Non-Qualified Stock Option (right to buy) · traded 1 June 2015 · filed 3 June 2015
had shares withheld for tax on 563 shares of Jazz PharmaceuticalsSEC Form 49 March 2015Ordinary Shares · traded 5 March 2015 · filed 9 March 2015
▼ sold on the open market 2,598 shares of Jazz PharmaceuticalsSEC Form 45 March 2015Ordinary Shares · traded 3 March 2015 · filed 5 March 2015
exercised options over 152 shares of Jazz PharmaceuticalsSEC Form 45 March 2015Ordinary Shares · traded 4 March 2015 · filed 5 March 2015
exercised options over 5,007 shares of Jazz PharmaceuticalsSEC Form 45 March 2015Ordinary Shares · traded 4 March 2015 · filed 5 March 2015
exercised options over 5,007 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 45 March 2015Incentive Stock Option (right to buy) · traded 4 March 2015 · filed 5 March 2015
exercised options over 152 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 45 March 2015Incentive Stock Option (right to buy) · traded 4 March 2015 · filed 5 March 2015
was granted 2,685 shares of Jazz PharmaceuticalsSEC Form 42 March 2015Ordinary Shares · traded 26 February 2015 · filed 2 March 2015
had shares withheld for tax on 373 shares of Jazz PharmaceuticalsSEC Form 42 March 2015Ordinary Shares · traded 27 February 2015 · filed 2 March 2015
was granted 565 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 42 March 2015Incentive Stock Option (right to buy) · traded 26 February 2015 · filed 2 March 2015
was granted 6,435 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 42 March 2015Non-Qualified Stock Option (right to buy) · traded 26 February 2015 · filed 2 March 2015
exercised options over 5,000 shares of Jazz PharmaceuticalsSEC Form 410 November 2014Ordinary Shares · traded 6 November 2014 · filed 10 November 2014
exercised options over 2,000 shares of Jazz PharmaceuticalsSEC Form 410 November 2014Ordinary Shares · traded 6 November 2014 · filed 10 November 2014
▼ sold on the open market 7,000 shares of Jazz PharmaceuticalsSEC Form 410 November 2014Ordinary Shares · traded 6 November 2014 · filed 10 November 2014
▼ sold on the open market 596 shares of Jazz PharmaceuticalsSEC Form 410 November 2014Ordinary Shares · traded 6 November 2014 · filed 10 November 2014
exercised options over 5,000 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 410 November 2014Nonstatutory Stock Option (right to buy) · traded 6 November 2014 · filed 10 November 2014
exercised options over 2,000 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 410 November 2014Nonstatutory Stock Option (right to buy) · traded 6 November 2014 · filed 10 November 2014
exercised options over 3,000 shares of Jazz PharmaceuticalsSEC Form 415 September 2014Ordinary Shares · traded 11 September 2014 · filed 15 September 2014
▼ sold on the open market 3,000 shares of Jazz PharmaceuticalsSEC Form 415 September 2014Ordinary Shares · traded 11 September 2014 · filed 15 September 2014
exercised options over 3,000 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 415 September 2014Incentive Stock Option (right to buy) · traded 11 September 2014 · filed 15 September 2014
exercised options over 2,500 shares of Jazz PharmaceuticalsSEC Form 410 September 2014Ordinary Shares · traded 8 September 2014 · filed 10 September 2014
▼ sold on the open market 2,500 shares of Jazz PharmaceuticalsSEC Form 410 September 2014Ordinary Shares · traded 8 September 2014 · filed 10 September 2014
exercised options over 2,500 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 410 September 2014Incentive Stock Option (right to buy) · traded 8 September 2014 · filed 10 September 2014
had shares withheld for tax on 1,956 shares of Jazz PharmaceuticalsSEC Form 413 August 2014Ordinary Shares · traded 11 August 2014 · filed 13 August 2014
exercised options over 2,500 shares of Jazz PharmaceuticalsSEC Form 49 July 2014Ordinary Shares · traded 7 July 2014 · filed 9 July 2014
▼ sold on the open market 2,500 shares of Jazz PharmaceuticalsSEC Form 49 July 2014Ordinary Shares · traded 7 July 2014 · filed 9 July 2014
exercised options over 2,500 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 49 July 2014Incentive Stock Option (right to buy) · traded 7 July 2014 · filed 9 July 2014
exercised options over 3,000 shares of Jazz PharmaceuticalsSEC Form 411 March 2014Ordinary Shares · traded 7 March 2014 · filed 11 March 2014
▼ sold on the open market 3,888 shares of Jazz PharmaceuticalsSEC Form 411 March 2014Ordinary Shares · traded 7 March 2014 · filed 11 March 2014
exercised options over 3,000 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 411 March 2014Nonstatutory Stock Option (right to buy) · traded 7 March 2014 · filed 11 March 2014
had shares withheld for tax on 782 shares of Jazz PharmaceuticalsSEC Form 46 March 2014Ordinary Shares · traded 5 March 2014 · filed 6 March 2014
exercised options over 11,250 shares of Jazz PharmaceuticalsSEC Form 43 March 2014Ordinary Shares · traded 27 February 2014 · filed 3 March 2014
▼ sold on the open market 8,000 shares of Jazz PharmaceuticalsSEC Form 43 March 2014Ordinary Shares · traded 27 February 2014 · filed 3 March 2014
▼ sold on the open market 3,250 shares of Jazz PharmaceuticalsSEC Form 43 March 2014Ordinary Shares · traded 27 February 2014 · filed 3 March 2014
was granted 3,750 shares of Jazz PharmaceuticalsSEC Form 43 March 2014Ordinary Shares · traded 27 February 2014 · filed 3 March 2014
exercised options over 11,250 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 43 March 2014Nonstatutory Stock Option (right to buy) · traded 27 February 2014 · filed 3 March 2014
was granted 6,853 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 43 March 2014Nonstatutory Stock Option (right to buy) · traded 27 February 2014 · filed 3 March 2014
was granted 647 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 43 March 2014Incentive Stock Option (right to buy) · traded 27 February 2014 · filed 3 March 2014
▼ sold on the open market 2,000 shares of Jazz PharmaceuticalsSEC Form 44 September 2013Ordinary Shares · traded 30 August 2013 · filed 4 September 2013
had shares withheld for tax on 1,409 shares of Jazz PharmaceuticalsSEC Form 413 August 2013Ordinary Shares · traded 9 August 2013 · filed 13 August 2013
was granted 6,000 shares of Jazz PharmaceuticalsSEC Form 46 March 2013Ordinary Shares · traded 5 March 2013 · filed 6 March 2013
was granted 11,250 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 46 March 2013Nonstatutory Stock Option (right to buy) · traded 5 March 2013 · filed 6 March 2013
was granted 750 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 46 March 2013Incentive Stock Option (right to buy) · traded 5 March 2013 · filed 6 March 2013
was granted 30,000 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 413 August 2012Option (right to buy) · traded 9 August 2012 · filed 13 August 2012
was granted 15,000 shares of Jazz PharmaceuticalsSEC Form 413 August 2012Ordinary Shares · traded 9 August 2012 · filed 13 August 2012
▼ sold on the open market 8,000 shares of Jazz PharmaceuticalsSEC Form 413 March 2012Ordinary Shares · traded 9 March 2012 · filed 13 March 2012
returned to the issuer 13,007 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 418 January 2012Incentive Stock Option (right to buy) · traded 18 January 2012 · filed 18 January 2012
returned to the issuer 10,292 shares of Jazz PharmaceuticalsSEC Form 418 January 2012Common Stock · traded 18 January 2012 · filed 18 January 2012
was granted 13,007 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 418 January 2012Incentive Stock Option (right to buy) · traded 18 January 2012 · filed 18 January 2012
was granted 10,292 shares of Jazz PharmaceuticalsSEC Form 418 January 2012Ordinary Shares · traded 18 January 2012 · filed 18 January 2012
exercised options over 36,993 shares of Jazz Pharmaceuticals (a derivative holding)SEC Form 413 January 2012Common Stock · traded 11 January 2012 · filed 13 January 2012

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.